Related Experiment Video
Updated: Jun 8, 2026

Implementing Patch Clamp and Live Fluorescence Microscopy to Monitor Functional Properties of Freshly Isolated PKD Epithelium
Published on: September 1, 2015
Reversion-inducing cysteine-rich protein with Kazal motifs interferes with epidermal growth factor receptor signaling
S Kitajima1, T Miki, Y Takegami
1Division of Oncology and Molecular Biology, Cancer Research Institute, Kanazawa University, Kanazawa, Ishikawa, Japan.
Abstract:
The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) gene had been isolated as an antagonist to RAS signaling; however, the mechanism of its action is not clear. In this study, the effect of loss of RECK function was assessed in various ways and cell systems. Successive cell cultivation of mouse embryonic fibroblasts (MEFs) according to 3T3 protocol revealed that the germline knockout of RECK confers accelerated cell proliferation and early escape from cellular senescence associated with downregulation of p19(Arf), Trp53 and p21(Cdkn1a). In contrast, short hairpin RNA-mediated depletion of RECK induced irreversible growth arrest along with several features of the Arf, Trp53 and Cdkn1a-dependent cellular senescence. Within 2 days of RECK depletion, we observed a transient increase in protein kinase B (AKT) and extracellular signal-regulated kinase (ERK) phosphorylation associated with an upregulated expression of cyclin D1, p19(Arf), Trp53, p21(Cdkn1a) and Sprouty 2. On further cultivation, RAS, AKT and ERK activities were then downregulated to a level lower than control, indicating that RECK depletion leads to a negative feedback to RAS signaling and subsequent cellular senescence. In addition, we observed that epidermal growth factor receptor (EGFR) activity was transiently upregulated by RECK depletion in MEFs, and continuously downregulated by RECK overexpression in colon cancer cells. These findings indicate that RECK is a novel modulator of EGFR signaling.
Insights
The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) gene, initially known to inhibit RAS signaling, was found to modulate epidermal growth factor receptor (EGFR) signaling, impacting cellular senescence and proliferation.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- The reversion-inducing cysteine-rich protein with Kazal motifs (RECK) gene was identified as a RAS signaling antagonist.
- The precise mechanism of RECK's action remained unclear.
Purpose of the Study:
- To elucidate the functional role of RECK in cellular processes.
- To investigate RECK's impact on RAS and EGFR signaling pathways.
Main Methods:
- Germline knockout and short hairpin RNA (shRNA)-mediated depletion of RECK in mouse embryonic fibroblasts (MEFs).
- 3T3 cell-cultivation protocol.
- Analysis of cell proliferation, senescence markers (p19Arf, p53, p21Cdkn1a), and signaling pathway activity (RAS, AKT, ERK, EGFR).
Main Results:
- RECK knockout led to accelerated proliferation and early senescence escape, with downregulated p19Arf, Trp53, and p21Cdkn1a.
- RECK depletion induced irreversible growth arrest and senescence, with transient AKT and ERK activation, followed by negative feedback on RAS signaling.
- RECK depletion transiently upregulated EGFR activity in MEFs, while RECK overexpression downregulated it in colon cancer cells.
Conclusions:
- RECK plays a dual role in regulating cell proliferation and senescence.
- RECK acts as a novel modulator of epidermal growth factor receptor (EGFR) signaling.
- Understanding RECK's function provides insights into cancer development and potential therapeutic strategies.
Related Concept Videos
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Mitogens and the Cell Cycle
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Receptor Tyrosine Kinases
The Ras Gene
Ras is a superfamily...
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
